Form 4 for AMRX Amneal Pharmaceuticals, Inc.
Accepted 2023-08-01 00:00:00 ET · period of report 2023-07-30 · accession 0001209191-23-043988 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-08-01 | 2023-07-30 | AMRX | Autor Deborah M. | Dir | M - OptEx | — | +54.9K | 54.9K | New | — |
| D | 2023-08-01 | 2023-07-30 | AMRX | Autor Deborah M. | Dir | M - OptEx | $0.00 | -54.9K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2023-07-30 | M | A | 54,949 | — | 54,949 | D | — | — | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. |
| 2 | Derivative | Restricted Stock Units | 2023-07-30 | M | D | 54,949 | $0.00 | 0 | D | — · — to — | 54,949 Class A Common Stock | (F1) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. (F2) On July 29, 2022 the reporting person was granted 54,949 restricted stock units vesting on July 30, 2023. |